Misclassification bias in estimating clinical severity of SARS-CoV-2 variants - Authors' reply.
作者信息
Nyberg Tommy, Ferguson Neil M, Blake Joshua, Hinsley Wes, Bhatt Samir, De Angelis Daniela, Thelwall Simon, Presanis Anne M
机构信息
MRC Biostatistics Unit, University of Cambridge, Cambridge CB2 0SR, UK.
NIHR Health Protection Research Unit for Modelling and Health Economics, MRC Centre for Global Infectious Disease Analysis, Jameel Institute, Imperial College London, London, UK.
出版信息
Lancet. 2022 Sep 10;400(10355):809-810. doi: 10.1016/S0140-6736(22)01432-5.
Abstract
摘要
相似文献
1
Misclassification bias in estimating clinical severity of SARS-CoV-2 variants - Authors' reply.关于评估新冠病毒变异株临床严重程度时的错误分类偏倚——作者回复
Lancet. 2022 Sep 10;400(10355):809-810. doi: 10.1016/S0140-6736(22)01432-5.
2
Misclassification bias in estimating clinical severity of SARS-CoV-2 variants.估计新冠病毒变异株临床严重程度时的错误分类偏倚。
Lancet. 2022 Sep 10;400(10355):809. doi: 10.1016/S0140-6736(22)01469-6.
3
Evaluating methodological approaches to assess the severity of infection with SARS-CoV-2 variants: scoping review and applications on Belgian COVID-19 data.评估评估 SARS-CoV-2 变异感染严重程度的方法学方法：范围综述及在比利时 COVID-19 数据上的应用。
BMC Infect Dis. 2022 Nov 11;22(1):839. doi: 10.1186/s12879-022-07777-6.
4
Lowering SARS-CoV-2 viral load might affect transmission but not disease severity in secondary cases - Authors' reply.降低严重急性呼吸综合征冠状病毒2（SARS-CoV-2）病毒载量可能影响传播，但不影响二代病例的疾病严重程度——作者回复
Lancet Infect Dis. 2021 Jul;21(7):915-916. doi: 10.1016/S1473-3099(21)00210-3. Epub 2021 Apr 14.
5
The importance of external quality assessment data in evaluating SARS-CoV-2 virus genome detection assays - Authors' reply.外部质量评估数据在评估严重急性呼吸综合征冠状病毒2（SARS-CoV-2）病毒基因组检测方法中的重要性——作者回复
Lancet Microbe. 2022 Mar;3(3):e169. doi: 10.1016/S2666-5247(22)00005-2. Epub 2022 Jan 25.
6
Laboratory-based molecular test alternatives to RT-PCR for the diagnosis of SARS-CoV-2 infection.基于实验室的分子检测替代 RT-PCR 用于 SARS-CoV-2 感染的诊断。
Cochrane Database Syst Rev. 2024 Oct 14;10(10):CD015618. doi: 10.1002/14651858.CD015618.
7
Bias and privacy in AI's cough-based COVID-19 recognition - Authors' reply.人工智能基于咳嗽的新冠肺炎识别中的偏差与隐私——作者回复
Lancet Digit Health. 2021 Dec;3(12):e761. doi: 10.1016/S2589-7500(21)00233-8.
8
Transmission of SARS-CoV-2: still up in the air - Authors' reply.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的传播：仍悬而未决——作者回复
Lancet. 2022 Feb 5;399(10324):519-520. doi: 10.1016/S0140-6736(21)02795-1.
9
Stability of SARS-CoV-2 in different environmental conditions - Authors' reply.严重急性呼吸综合征冠状病毒2在不同环境条件下的稳定性——作者回复
Lancet Microbe. 2020 Aug;1(4):e146. doi: 10.1016/S2666-5247(20)30095-1. Epub 2020 Aug 6.
10
Cytokines as predictors of COVID-19 severity: evidence from a meta-analysis. Authors' reply.细胞因子作为COVID-19严重程度的预测指标：一项荟萃分析的证据。作者的回复。
Pol Arch Intern Med. 2021 Jan 29;131(1):99-100. doi: 10.20452/pamw.15793.
引用本文的文献
1
Increased vaccine sensitivity of an emerging SARS-CoV-2 variant.新型 SARS-CoV-2 变体疫苗敏感性增加。
Nat Commun. 2023 Jun 29;14(1):3854. doi: 10.1038/s41467-023-39567-2.
本文引用的文献
1
Severity of omicron variant of concern and effectiveness of vaccine boosters against symptomatic disease in Scotland (EAVE II): a national cohort study with nested test-negative design.苏格兰关注的奥密克戎变异株的严重程度和疫苗加强针预防有症状疾病的效果（EAVE II）：一项具有巢式病例对照研究设计的全国队列研究。
Lancet Infect Dis. 2022 Jul;22(7):959-966. doi: 10.1016/S1473-3099(22)00141-4. Epub 2022 Apr 22.
2
Risk of hospitalisation associated with infection with SARS-CoV-2 omicron variant versus delta variant in Denmark: an observational cohort study.丹麦的一项观察性队列研究：感染 SARS-CoV-2 奥密克戎变异株与德尔塔变异株导致住院的风险比较。
Lancet Infect Dis. 2022 Jul;22(7):967-976. doi: 10.1016/S1473-3099(22)00154-2. Epub 2022 Apr 22.
3
Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study.比较分析英国住院和死亡风险与 SARS-CoV-2 奥密克戎（B.1.1.529）和德尔塔（B.1.617.2）变异株的关系：一项队列研究。
Lancet. 2022 Apr 2;399(10332):1303-1312. doi: 10.1016/S0140-6736(22)00462-7. Epub 2022 Mar 16.
4
Reduced risk of hospitalisation among reported COVID-19 cases infected with the SARS-CoV-2 Omicron BA.1 variant compared with the Delta variant, Norway, December 2021 to January 2022.与德尔塔变异株相比，报告的 COVID-19 病例中感染 SARS-CoV-2 奥密克戎 BA.1 变异株的住院风险降低，挪威，2021 年 12 月至 2022 年 1 月。
Euro Surveill. 2022 Jan;27(4). doi: 10.2807/1560-7917.ES.2022.27.4.2200077.
Zotero 插件